Public Sector Pension Investment Board Has $32.75 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Public Sector Pension Investment Board raised its stake in Kenvue Inc. (NYSE:KVUE) by 1,822.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,415,737 shares of the company’s stock after buying an additional 1,342,100 shares during the period. Public Sector Pension Investment Board owned 0.07% of Kenvue worth $32,746,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KVUE. Riverview Trust Co bought a new position in shares of Kenvue during the third quarter valued at $30,000. Ashton Thomas Securities LLC acquired a new position in Kenvue during the 3rd quarter worth about $35,000. Deseret Mutual Benefit Administrators grew its position in shares of Kenvue by 49.7% in the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company’s stock valued at $45,000 after buying an additional 651 shares during the last quarter. Studio Investment Management LLC increased its stake in shares of Kenvue by 52.1% in the second quarter. Studio Investment Management LLC now owns 2,468 shares of the company’s stock valued at $45,000 after buying an additional 845 shares during the period. Finally, Brooklyn Investment Group bought a new position in shares of Kenvue during the third quarter worth about $71,000. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on KVUE shares. Bank of America upped their target price on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a research report on Tuesday, September 24th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. UBS Group lifted their price target on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Finally, Piper Sandler increased their price objective on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $22.64.

Kenvue Stock Performance

Shares of Kenvue stock opened at $24.12 on Thursday. The company has a market cap of $46.24 billion, a PE ratio of 43.85, a price-to-earnings-growth ratio of 2.20 and a beta of 1.36. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The business has a 50 day moving average price of $22.89 and a 200-day moving average price of $20.94.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter in the prior year, the company posted $0.31 earnings per share. The firm’s revenue for the quarter was down .4% on a year-over-year basis. Equities analysts anticipate that Kenvue Inc. will post 1.07 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th were given a $0.205 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.40%. Kenvue’s dividend payout ratio is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.